-
Report details
-
15
Figures
-
72
Tables
-
Chapter One: Executive Summary
-
Introduction
-
IVD Procedure Volume Estimate and Forecast
-
Scope & Methodology
-
About Kalorama Information
-
Chapter Two: Introduction
-
Overview
-
Industry Trends
-
Demographic Trends
-
Global Population and Aging
-
Workforce Reduction
-
Increase in Chronic Diseases
-
Personalized Medicine
-
New Infectious Disease Threats
-
Tickborne Diseases (TBDs)
-
Zika
-
Chagas
-
Dengue
-
Ebola
-
Chikungunya
-
Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)
-
Marburg
-
SARS-CoV-2 (COVID-19)
-
Monkeypox
-
Emerging and Emerged Markets
-
Chapter Three: IVD Testing Segments
-
IVD Testing Trends
-
Segment Growth Projections
-
POC Testing
-
Clinical Chemistry
-
Immunoassays
-
Mass Spectrometry (Immuno)
-
Molecular Assays
-
Hematology
-
Coagulation
-
Conventional Microbiology
-
Blood Grouping/Typing
-
Histology/Cytology
-
Chapter Four: Global IVD Markets
-
General
-
North America
-
Mexico, Central & South America
-
Brazil
-
Mexico
-
Other Central & South America
-
Western Europe
-
France
-
Germany
-
Italy
-
Spain
-
United Kingdom
-
Other Western Europe
-
Eastern Europe
-
Russia
-
Other Eastern Europe
-
Asia/Pacific
-
China
-
Japan
-
Other Asian Countries and Territories
-
Middle East
-
Africa
-
Chapter Five: Point-of-Care (POC) Procedures
-
Global POC Procedure Volume by Test Type
-
POC Self Tests
-
Traditional Blood Glucose Monitoring Activities
-
Continuous Blood Glucose Monitoring
-
Pregnancy and Fertility Testing
-
Coagulation Testing
-
Fecal Occult Blood Testing
-
Drugs of Abuse Testing
-
H. Pylori Testing
-
HIV Testing
-
Infectious Disease
-
Cholesterol Testing
-
POC Urinalysis Testing
-
Other POC Self-Testing
-
POC Self-Testing Product Sales
-
Pricing Trends
-
POC Professional Testing
-
POC Professional Blood Glucose Testing Procedures
-
POC Professional Critical Care Testing
-
POC Fertility Testing
-
POC Professional Infectious Disease Testing
-
POC Professional Cardiac Marker Testing
-
POC Professional Cholesterol/Lipid Testing
-
POC Professional Coagulation Testing
-
POC Professional HbA1C Testing
-
POC Professional Hematology Testing
-
POC Professional Fecal Occult Blood Screening
-
POC Professional Drugs of Abuse Testing
-
POC Professional Urinalysis Testing
-
Other POC Professional Testing
-
POC IVD Product Sales
-
Pricing Trends
-
Chapter Six: Clinical Chemistry Procedures
-
Types of Tests
-
General Chemistry
-
Blood Gases & Electrolytes
-
Urinalysis
-
Global Sales of Clinical Chemistry Products
-
Pricing Trends
-
Chapter Seven: Immunoassay Procedures
-
Technologies
-
Labeling Techniques
-
Enzyme Immunoassays
-
Fluorescence Polarization Immunoassays (FPIAs)
-
Radioimmunoassays (RIAs)
-
Testing Procedures & Product Sales
-
Cardiac Markers
-
Tumor Markers
-
Autoimmune Conditions
-
Allergy Conditions
-
Thyroid Conditions
-
Proteins
-
Anemia
-
Fertility Testing
-
Therapeutic Drug Monitoring
-
Vitamin D
-
Diabetes/HbA1c
-
Drugs of Abuse
-
Infectious Diseases
-
Instruments
-
Pricing Trends
-
Chapter Eight: Molecular Testing Procedures
-
Types of Test
-
Testing Technologies
-
Infectious Diseases
-
Blood Screening
-
Cancer
-
Transplant Matching
-
Thrombophilia SNPs
-
Inherited Diseases
-
Other Molecular Tests
-
Prenatal
-
Global Sales of Molecular IVD Products
-
Pricing Trends
-
Chapter Nine: Laboratory-Based Hematology Procedures
-
Types of Tests
-
Global Sales of Hematology Products
-
Pricing Trends
-
Chapter Ten: Coagulation Testing Procedures
-
Types of Tests
-
Global Sales of Coagulation Products
-
Pricing Trends
-
Chapter Eleven: Microbiology Procedures
-
Types of Tests
-
ID/AST Automated Panels & Reagents
-
Manual Panels & Reagents
-
Blood Culture
-
Chromogenic Media
-
Rapid Microbiological Tests
-
Mass Spectrometry
-
Global Sales of Conventional IVD Microbiology Products
-
ID/AST Panels & Reagents
-
Blood Culture
-
Chromogenic Media
-
Rapid Microbiological Tests
-
Mass Spectrometry
-
Pricing Trends
-
Chapter Twelve: Blood Grouping/Typing Procedures
-
Types of Tests
-
Blood Grouping/Typing Product Sales
-
Pricing Trends
-
Chapter Thirteen: Histology/Cytology Procedures
-
Types of Tests
-
Pap Tests
-
In Situ Hybridization Tests
-
Immunohistochemistry Tests
-
Traditional Non-Pap Stains
-
Circulating Tumor Cells
-
Flow Cytometry
-
Histology/Cytology IVD Product Sales
-
Pricing Trends
-
Chapter Fourteen: Company Profiles
-
Abbott Diagnostics
-
Recent Revenue History
-
Core Lab
-
Hematology
-
Blood Banking
-
Infectious Diseases - Molecular
-
Diabetes
-
HIV Point of Care
-
i-STAT Business
-
COVID-19
-
Agilent Technologies
-
Recent Revenue History
-
Agilent in Genomics
-
Cytogenetic Analysis
-
Sequencing
-
Flow Cytometry
-
Companion Diagnostics - Dako
-
COVID-19
-
Beckman Coulter
-
Recent Revenue History
-
Hematology
-
Clinical Chemistry
-
Immunoassays
-
Microbiology
-
Blood Banking
-
COVID-19
-
Becton, Dickinson and Company (BD)
-
Recent Revenue History
-
Cytology
-
Molecular Microbiology
-
Traditional Microbiology - ID/AST
-
Blood Culture
-
Hospital Acquired Infections
-
Blood Collection
-
Mass Spectrometry
-
COVID-19
-
bioMérieux Inc.
-
Recent Revenue History
-
Traditional Microbiology
-
Blood Culture
-
Immunoassays
-
Mass Spectrometry
-
BioFire Diagnostics Business
-
COVID-19
-
Bio-Rad Laboratories, Inc.
-
Recent Revenue History
-
Blood Bank
-
Immunoassays
-
COVID-19
-
Bruker Corporation
-
Recent Revenue History
-
Acquisitions and Collaborations
-
Mass Spectrometry
-
Microbiology
-
Molecular PCR
-
COVID-19
-
Cepheid / Danaher
-
Recent Revenue History
-
GeneXpert/ Xpress Line
-
Tuberculosis
-
Microbiology
-
POC Testing
-
Cancer
-
COVID-19
-
Danaher Corporation
-
Dexcom
-
DiaSorin
-
Recent Revenue History
-
Immunoassays
-
Molecular
-
COVID-19
-
Exact Sciences
-
Recent Revenue History
-
COVID-19
-
Hologic, Inc.
-
Recent Revenue History
-
PANTHER Molecular System
-
HIV Testing
-
Sexually Transmitted Infections
-
Infectious Diseases
-
Cytology
-
COVID-19
-
Illumina
-
Recent Revenue History
-
COVID-19
-
Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
-
Natera
-
Recent Revenue History
-
Prenatal Paternity Testing
-
QIAGEN
-
Recent Revenue History
-
Tuberculosis
-
Precision Medicine / Companion Diagnostics
-
Molecular Microbiology
-
Prenatal Testing
-
Next Generation Sequencing
-
Liquid Biopsy
-
COVID-19
-
QuidelOrtho Corporation
-
Recent Revenue History
-
Immunoassays
-
Rapid Immunoassays
-
The Solana Business
-
Molecular – Savanna
-
Blood Bank
-
COVID-19
-
Radiometer A/S / Danaher
-
Recent Revenue History
-
Critical Care
-
Immunoassays
-
HemoCue
-
Roche Diagnostics
-
Recent Revenue History
-
Hematology
-
Core Lab
-
Immunoassays
-
HIV
-
Core Molecular
-
Digital PCR
-
Diabetes Care
-
Coagulation
-
cobas Liat System – POC
-
HPV
-
Blood Bank
-
Transplant Medicine
-
Cancer Companion Testing
-
COVID-19
-
Siemens Healthineers (Siemens)
-
Recent Revenue History
-
Core Lab
-
Immunoassays
-
Hematology
-
Molecular
-
Acute Care – POC
-
COVID-19
-
Sysmex Corporation
-
Recent Revenue History
-
Hematology
-
Coagulation
-
Urinalysis
-
Immunoassays
-
Precision Medicine / Companion Test Diagnostics
-
Oncology
-
COVID-19
-
Thermo Fisher Scientific Inc.
-
Recent Revenue History
-
Immunoassays
-
Microbiology
-
Next Generation Sequencing
-
Molecular and qPCR
-
Mass Spectrometry
-
COVID-19
-
Ventana Medical Systems Inc. / Roche Tissue Diagnostics
-
Recent Revenue History
-
Immunohistochemistry - IHC
-
Cervical Cancer Screening
-
Companion Diagnostics
-
Werfen
-
Recent Revenue History
-
Hematology and Coagulation
-
Autoimmunity
|
In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028
22 Sep 2023
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed.
This report is an essential resource for the IVD business planner. It is intended to serve as a companion piece to Kalorama’s major IVD publication (i.e., The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition).
Kalorama’s IVD procedures report presents projections covering the 2023 to 2028 period for:
- the global number of IVD procedures by type (self and professional point-of-care, clinical chemistry, immunoassay, molecular, hematology, coagulation, microbiology, blood banking, and histology/cytology)
- the total number of IVD tests by region and selected countries
- the average and total worldwide cost of various IVD tests
The report estimates IVD test procedure volume and IVD pricing for the following segments:
- Worldwide IVD Market and Test Volume
- Point-of-Care (POC) Market and Test Volume
- Clinical Chemistry Market and Test Volume
- Molecular Market and Test Volume
- Laboratory-based Hematology Market and Test Volume
- Coagulation Market and Test Volume
- Microbiology Market and Test Volume
- Blood Banking Market and Test Volume
- COVID-19 Market and Test Volume
- Histology/Cytology Market and Test Volume
- Immunoassay Market and Test Volume
Page Count: 394
|
More information about this product
Other Users Also Viewed
24 Aug 2023
The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions.…
|
